Menagene Pharmaceutical Industries

Menagene Pharmaceutical Industries is a leading Iranian biotechnology company focused on the development and commercialization of high-value biosimilars and recombinant proteins. The company operates a state-of-the-art manufacturing facility in the Alborz Pharmaceutical Park, where it produces complex biologics for the treatment of chronic and life-threatening conditions. Its product portfolio includes biosimilar versions of teriparatide, pegfilgrastim, and somatropin, targeting therapeutic areas such as endocrinology, oncology, and rheumatology. Menagene integrates advanced upstream and downstream bioprocessing technologies to ensure high-quality production standards. By focusing on local manufacturing, the company plays a critical role in improving patient access to biological therapies in the Middle East region.